{
    "2019-06-10": [
        [
            {
                "time": "",
                "original_text": "一季报负增长已成定论 康恩贝上年财报指标背离 上交所问询",
                "features": {
                    "keywords": [
                        "一季报",
                        "负增长",
                        "康恩贝",
                        "财报指标",
                        "背离",
                        "上交所问询"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "34亿元花哪去了？康恩贝销售费用占营收比超5成引问询",
                "features": {
                    "keywords": [
                        "34亿元",
                        "销售费用",
                        "营收比",
                        "康恩贝",
                        "问询"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}